The weekly litigation news digest is live. Subscribe now

IP Verse

Viropharma Biologics competitive analysis

Loading summary...

Latest patents of Viropharma Biologics opposed by its competitors

Explore Viropharma Biologics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3574914
Dec 29, 2021Corticosteroid Compositions1
EP2585075
Sep 22, 2021Methods Of Treatment For Esophageal Inflammation1
EP3354276
Jan 1, 2020Compositions For The Treatment Of Gastrointestinal Inflammation2
EP2968434
Jun 28, 2017C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor Deficency2

Latest PTAB cases involving Viropharma Biologics

Discover the latest PTAB cases involving Viropharma Biologics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Viropharma Biologics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
VIROPHARMA BIOLOGICS - 6 - -
AECHTER35 - - -
CSL BEHRING394 -
DR FALK PHARMA1026 -